School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

QIAGEN N.V. QGEN

Healthcare · Diagnostics & Research

$45.44last close 2026-10-13 · market cap $9.38B · delayed data

Trailing returns

1M+6.92%
3M+9.65%
6M+9.40%
1Y-2.90%
5Y-10.25%

Basis: Adjusted daily closes.

What it does

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary…

Open QGEN in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies